C4 Therapeutics Inc at UBS Global Healthcare Virtual Conference Transcript
Good morning, and thank you, everyone, for joining the Virtual UBS Global Healthcare Conference. I'm Colin Bristow, one of the biotech analysts here at UBS. And it's my pleasure to have our top pick C4 here with us today. So speaking on behalf of the company, we have Andrew Hirsch, CEO; Stew Fisher, CFO; and Adam Crystal, CMO. So Andrew and team, thank you for joining us today.
Before we start, if anyone has a question, there is a question function in this global meet system. But alternatively, feel free to e-mail me at [email protected], and I'm happy to fill the question for you.
So with that, I'll hand it over to Andrew. Please go ahead.
Yes. Thanks, Colin, and thanks to -- for UBS for hosting us. I did want to note that we have some exciting news that we announced this morning. As many of you know, we have been evaluating whether or not to take our EGFR program forward into the clinic and this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
